Home Merck Announces Sale of Consumer Care Business to Bayer AG for $14.2 Billion
 

Keywords :   


Merck Announces Sale of Consumer Care Business to Bayer AG for $14.2 Billion

2014-05-06 12:00:00| Merck.com - Financial News

Dateline City: BOSTON Enters into Worldwide Collaboration with Bayer to Market and Develop Novel Therapies for Cardiovascular Disease Collaboration Includes a $1 Billion Up-front Payment by Merck to Bayer BOSTON--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced that it has entered into a definitive agreement to sell its Merck Consumer Care (MCC) business to Bayer AG (BAYRY) for $14.2 billion. Under the terms of the agreement, Bayer AG will acquire Mercks existing OTC business, including the global trademark and prescription rights for Claritin and Afrin. Language: English Contact: MerckMedia:Steve Cragle, 908-423-3461Pam Eisele, 267-305-3558orInvestors:Joe Romanelli, 908-423-5185Carol Ferguson, 908-423-4465 Ticker Slug: Ticker: MRK Exchange: NYSE read more

Tags: business care sale consumer

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
05.11PM responds to Sir Alan Bates after repeated requests
05.11American Angus elects 2024-25 board leaders
05.11Atlantic Tropical Weather Outlook
05.11Eastern North Pacific Tropical Weather Outlook
05.11Tropical Storm Rafael Graphics
05.11Tropical Storm Rafael Public Advisory Number 8A
05.11Summary for Tropical Storm Rafael (AT3/AL182024)
05.11Brazil gives green light to medicinal use of Cannabis in animals
More »